The London fibromyalgia epidemiology study: Direct health care costs of fibromyalgia syndrome in London, Canada

Journal of Rheumatology

Volumn 26, Issue 4, 1999, Pages 885-889

  White, Kevin P ^a,b   Speechley, Mark ^a   Harth, Manfred ^a   Østbye, Trüls ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Epidemiology; Fibromyalgia Syndrome; Health Care Costs

Indexed keywords

ADULT; ARTICLE; CANADA; CHRONIC DISEASE; CHRONIC PAIN; CONTROLLED STUDY; FEMALE; FIBROMYALGIA; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REIMBURSEMENT; RHEUMATIC DISEASE;

ADULT; DEMOGRAPHY; FEMALE; FIBROMYALGIA; HEALTH CARE COSTS; HEALTH SERVICES; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; MALE; MIDDLE AGED; OFFICE VISITS; ONTARIO; PAIN; SYNDROME;

EID: 0032916016     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Lawrence RC, Hochberg MC, Kelsey JL, et al. Estimates of prevalence of selected arthritic and musculoskeletal diseases in the United States. J Rheumatol 1989;16:427-41.
2. Felts W, Yelin E. The economic impact of the rheumatic diseases in the United States. J Rheumatol 1989;16:867-84.
3. Wood PHN, Badley EM. Rheumatic Disorders. In: Miller DL, Farmer RDT, editors. Epidemiology of diseases. Oxford: Blackwell Scientific; 1982:333-46.
4. Reynolds DL, Chambers LW, Badley EM, et al. Physical disability among Canadians reporting musculoskeletal diseases. J Rheumatol 1992;19:1020-30.
5. Lee P, Helewa A, Smythe HA, Bombardier C, Goldsmith CH. Epidemiology of musculoskeletal disorders (complaints) and related disability in Canada. J Rheumatol 1985;12:1169-73.
6. Badley EH, Yoshida K, Webster G, Stephens M. Ontario Health Survey 1990, Working Paper No. 5: Disablement and chronic health problems in Ontario. Ministry of Health Ontario, 1993.
7. Spitzer WO, Harth MH, Goldsmith CH, et al. The arthritis complaint in primary care: prevalence, related disability, and costs. J Rheumatol 1976;3:88-99.
8. Felts W, Yelin E. The economic impact of the rheumatic disorders in the United States. J Rheumatol 1989;16:867-84.
9. Yelin E, Callahan LF. The economic cost and social and psychological impact of musculoskeletal conditions. Arthritis Rheum 1995;38:1351-62.
10. Wolfe F. The clinical syndrome of fibrositis. Am J Med 1986;81(3A):7-14.
11. Hawley DJ, Wolfe F. Pain, disability, and pain/disability relationships in seven rheumatic disorders: a study of 1,522 patients. J Rheumatol 1991;18:1552-7.
12. Martinez JE, Ferraz MB, Sato EI, Atra E. Fibromyalgia versus rheumatoid arthritis: a longitudinal comparison of the quality of life. J Rheumatol 1995;22:270-4.
13. Burckhardt CS, Clark SR, Bennett RM. Fibromyalgia and quality of life: a comparative analysis. J Rheumatol 1993:20:475-9.
14. Bruusgaard D, Evensen AR, Bjerkedal T. Fibromyalgia - a new cause for disability pension. Scand J Soc Med 1993;21:116-9.
15. Ochoa JL. Essence, investigation, and management of "neuropathic" pains: Hopes from acknowledgement of chaos. Muscle Nerve 1993:16:977-1008.
16. Hadler NM. Occupational musculoskeletal disorders. New York: Raven Press; 1993:16-33.
17. Wallace DJ. Systemic lupus erythematosus, rheumatology and medical literature: Current trends. J Rheumatol 1985:12:913-5.
18. Wolfe F, Anderson J, Harkness D, et al. A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis Rheum 1997:40:1560-70.
19. O'Rourke D, Blair J. Improving random respondent selection in telephone surveys. J Market Res 1983;20:428-32.
20. White KP, Harth M, Speechley M, Østbye T.Testing an instrument to screen for FMS in general population studies: The London Fybromyalgia Epidemiology Study screening questionaire. J Rheumatol 1999;26:880-4.
21. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 1990;33:160-72.
22. SAS Release 6.12. Cary, North Carolina: SAS Institute Inc., 1996.
23. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995:38:19-28.
24. Wolfe F, Anderson A, Harkness D, et al. A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis Rheum 1997:40:1560-70.
25. White K, Speechley M, Harth M, Østbye T. The London Fibromyalgia Epidemiology Study: estimating the number of Canadian adults with fibromyalgia [abstract]. Arthritis Rheum 1997:40:85187.
26. McCain G, Cameron R, Kennedy JC. The problem of long term disability payments and litigation in primary fibromyalgia: the Canadian perspective. J Rheumatol 1989; 16 Suppl 19:174-6.
27. Yelin E, Callahan LF. The economic cost and social and physical impact of musculoskeletal conditions. Arthritis Rheum 1995:38:1351-62.